Secondary Logo

October 2014 - Volume 36 - Issue 5
pp: 553-691

Possible False-Negative Results on Therapeutic Drug Monitoring of Phenytoin Using a Particle Enhanced Turbidimetric Inhibition Immunoassay in a Patient With a High Level of IgM

Hirata, Kenshiro; Saruwatari, Junji; Enoki, Yuhuki; More

Therapeutic Drug Monitoring. 36(5):553-555, October 2014.

Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

Suzuki, Takeshi; Mihara, Kazuo; Nakamura, Akifumi; More

Therapeutic Drug Monitoring. 36(5):651-655, October 2014.

Impact of Clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns

Fonzo-Christe, Caroline; Guignard, Bertrand; Zaugg, Claudia; More

Therapeutic Drug Monitoring. 36(5):656-662, October 2014.